Image

An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease

Study on ABBV-951 infusion effects in Japanese adults with Parkinson's.

Recruiting
15 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

Parkinson's disease (PD) is a brain condition that makes people shake, feel stiff, and move slowly. This study looks at how safe and helpful a medicine named ABBV-951 is for treating PD in Japan. ABBV-951 is already allowed to be used for PD in Japan. Around 250 adults, aged 15 and older, who have PD and are already taking ABBV-951 will join the study. They will be observed for about one year, or 52 weeks. The study will not add any extra visits or tasks for the participants. They will continue their regular treatment and check-ups with their doctors, which can happen in person or online.

  • Participants will be followed for 52 weeks (1 year).
  • No additional burden; visits can be on-site or virtual.
  • Must not have used ABBV-951 before or be in other clinical trials.
Print
Study details
    Parkinson's Disease (PD)

NCT05916157

AbbVie

17 April 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.